Yan, Yujie
Kehayias, Christopher
He, John
Aerts, Hugo J. W. L.
Fitzgerald, Kelly J.
Kann, Benjamin H.
Kozono, David E.
Guthier, Christian V.
Mak, Raymond H.
Funding for this research was provided by:
National Institutes of Health (5U01CA209414)
Article History
Received: 9 August 2023
Accepted: 19 December 2023
First Online: 30 January 2024
Competing interests
: H.J.W.L.A.: Leadership: Sphera; Stock and Other Ownership Interests: Onc.AI; Consulting or Advisory Role: Onc.AI R.H.M.: Research grant: ViewRay; Advisory Board: ViewRay, AstraZeneca. Honorarium: Novartis, Varian; Travel expenses: ViewrRay. The remaining authors declare no competing interest.